期刊
FASEB JOURNAL
卷 26, 期 11, 页码 4685-4695出版社
FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.12-212282
关键词
SNRK; CacyBP
资金
- U.S. National Institutes of Health [K02 HL107448, R01 HL087149, R01 HL104181, P01 HL108795]
- American Heart Association
Sucrose nonfermenting 1 (Snf1)-related kinase (SNRK) is a serine/threonine kinase with sequence similarity to AMP-activated protein kinase (AMPK); however, its function is not well characterized. We conducted a gene array to determine which genes are regulated by SNRK. The array demonstrated that SNRK overexpression increased the levels of genes involved in cell proliferation, including calcyclin-binding protein (CacyBP), a member of the ubiquitin ligase complex that targets nonphosphorylated beta-catenin for degradation. We confirmed that SNRK increased CacyBP mRNA and protein, and decreased beta-catenin protein in HCT116 and RKO colon cancer cells. Furthermore, SNRK inhibited colon cancer cell proliferation, and CacyBP down-regulation reversed the SNRK-mediated decrease in proliferation and beta-catenin. SNRK overexpression also decreased beta-catenin nuclear localization and target gene transcription, and beta-catenin down-regulation reversed the effects of SNRK knockdown on proliferation. SNRK transcript levels were reduced in human colon tumors compared to normal tissue by 35.82%, and stable knockdown of SNRK increased colon cancer cell tumorigenicity. Our results demonstrate that SNRK is down-regulated in colon cancer and inhibits colon cancer cell proliferation through CacyBP up-regulation and beta-catenin degradation, resulting in reduced proliferation signaling. These findings reveal a novel function for SNRK in the regulation of colon cancer cell proliferation and beta-catenin signaling.-Rines, A. K., Burke, M. A., Fernandez, R. P., Volpert, O. V., Ardehali, H. Snf1-related kinase inhibits colon cancer cell proliferation through calcyclin binding protein-dependent reduction of beta-catenin. FASEB J. 26, 4685-4695 (2012). www.fasebj.org
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据